As of 2024-12-12, the Relative Valuation of 89Bio Inc (ETNB) is (36.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.04 USD, the upside of 89Bio Inc based on Relative Valuation is -557.7%.
The range of the Relative Valuation is (43.74) - (44.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 18.3x | 18.0x |
| Forward P/E multiples | 5.1x - 18.7x | 11.9x |
| Fair Price | (43.74) - (44.97) | (36.80) |
| Upside | -644.1% - -659.4% | -557.7% |
| Date | P/E |
| 2024-12-03 | -3.88 |
| 2024-12-02 | -3.84 |
| 2024-11-29 | -3.66 |
| 2024-11-27 | -3.72 |
| 2024-11-26 | -3.62 |
| 2024-11-25 | -3.65 |
| 2024-11-22 | -3.56 |
| 2024-11-21 | -3.41 |
| 2024-11-20 | -3.25 |
| 2024-11-19 | -3.25 |
| 2024-11-18 | -3.25 |
| 2024-11-15 | -3.23 |
| 2024-11-14 | -3.56 |
| 2024-11-13 | -3.63 |
| 2024-11-12 | -3.68 |
| 2024-11-11 | -4.09 |
| 2024-11-08 | -4.25 |
| 2024-11-07 | -4.05 |
| 2024-11-06 | -4.14 |
| 2024-11-05 | -3.76 |
| 2024-11-04 | -3.78 |
| 2024-11-01 | -3.72 |
| 2024-10-31 | -3.17 |
| 2024-10-30 | -3.25 |
| 2024-10-29 | -3.33 |
| 2024-10-28 | -3.26 |
| 2024-10-25 | -3.20 |
| 2024-10-24 | -3.16 |
| 2024-10-23 | -3.18 |
| 2024-10-22 | -3.30 |
| 2024-10-21 | -3.31 |
| 2024-10-18 | -3.40 |
| 2024-10-17 | -3.34 |
| 2024-10-16 | -3.50 |
| 2024-10-15 | -3.26 |
| 2024-10-14 | -3.22 |
| 2024-10-11 | -3.17 |
| 2024-10-10 | -3.03 |
| 2024-10-09 | -2.97 |
| 2024-10-08 | -3.02 |
| 2024-10-07 | -2.98 |
| 2024-10-04 | -2.93 |
| 2024-10-03 | -2.91 |
| 2024-10-02 | -2.95 |
| 2024-10-01 | -2.99 |
| 2024-09-30 | -3.01 |
| 2024-09-27 | -2.95 |
| 2024-09-26 | -2.99 |
| 2024-09-25 | -3.02 |
| 2024-09-24 | -3.08 |